Avalo Therapeutics(AVTX)
WAYNE, PA
BiotechnologyFocus: Small molecules for neuro / psychiatric disorders
Avalo Therapeutics is a life sciences company focused on Small molecules for neuro / psychiatric disorders.
Psychiatry
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
A Noninterventional Genotype/Phenotype Study of mGluR Mutations in Children and Adolescents With ADH
Attention Deficit Disorder With HyperactivityClinical Trials (1)
NCT02811211A Noninterventional Genotype/Phenotype Study of mGluR Mutations in Children and Adolescents With ADHD
N/AA Non-interventional Study to Identify Children and Adolescents With ADHD and With or Without mGLuR
Attention Deficit Hyperactivity DisorderClinical Trials (1)
NCT03233867A Non-interventional Study to Identify Children and Adolescents With ADHD and With or Without mGLuR Mutations
N/APhase 1
Clinical Trials (1)
NCT02895906Safety and Efficacy Study of NFC-1 in Subjects Aged 12-17 Years With 22q11.2DS & Associated Neuropsychiatric Conditions
Phase 1Phase 1
Clinical Trials (1)
NCT02286817Phase I Single Dose, Open-Label Pharmacokinetic Study and Single-Blind, Placebo-Controlled Dose Escalation Study of NFC-1 in Adolescents With Attention-Deficit Hyperactivity Disorder
Phase 1CERC-006
Lymphatic MalformationClinical Trials (1)
NCT04994002A Pharmacokinetic, Pharmacodynamic, Safety and Tolerability Study of CERC-006 in Adults With Complex Lymphatic Malformations
Phase 1NFC-1 100 mg
Attention Deficit Disorder With HyperactivityClinical Trials (1)
NCT03006367Pharmacokinetic and Tolerability Study of NFC-1 in Subjects Aged 6-17 Years With ADHD
Phase 1AEVI-007
Multiple MyelomaClinical Trials (1)
NCT04671251Phase 1b Study of AEVI-007 in Subjects With Relapsed or Refractory Multiple Myeloma
Phase 1FP01
HealthyClinical Trials (1)
NCT01579526A Single Dose Study to Determine the Safety and Pharmacokinetics of FP01 Lozenges in Healthy Volunteers
Phase 1MDGN-002
Crohn DiseaseClinical Trials (1)
NCT03169894Evaluation of the Safety, Tolerability, and Efficacy of MDGN-002 in Adults With Moderate to Severe Active Crohn's Disease or Ulcerative Colitis
Phase 1MDGN201 TARGTEPO
Anemia of End Stage Renal DiseaseClinical Trials (1)
NCT02468414TARGTEPO Treatment for Anemia in PD US Trial
Phase 2CERC-301
Major Depressive DisorderClinical Trials (1)
NCT02459236A Study of Intermittent Doses of CERC-301 in MDD
Phase 2Phase 2
Clinical Trials (1)
NCT03609619PART B: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and Without mGluR Mutations
Phase 2CERC-002
COVID-19 PneumoniaClinical Trials (1)
NCT04412057Clinical Trial to Evaluate CERC-002 in Adults With COVID-19 Pneumonia and Acute Lung Injury
Phase 2AVTX-009 Regimen 1
Hidradenitis SuppurativaClinical Trials (1)
NCT06603077A Study to Evaluate the Efficacy and Safety of AVTX-009 in Patients With Moderate to Severe Hidradenitis Suppurativa
Phase 2Phase 2
Clinical Trials (1)
NCT03265119PART A: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and With mGluR Mutations
Phase 2CERC-301
Major Depressive DisorderClinical Trials (1)
NCT01941043A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
Phase 2Phase 2
Clinical Trials (1)
NCT01703923An Exploratory Study of FP01 Lozenges in Subjects With Chronic Refractory Cough
Phase 2FP01
Acute CoughClinical Trials (1)
NCT01597349Antitussive Effects of FP01 Lozenges in Subjects With Cough Due to Upper Respiratory Tract Infection
Phase 2AVTX-002
Non-Eosinophilic AsthmaClinical Trials (1)
NCT05288504A Study to Evaluate the Safety and Efficacy of AVTX-002 for the Treatment of Poorly Controlled Non-Eosinophilic Asthma.
Phase 2Phase 2/3
Clinical Trials (1)
NCT02777931Efficacy and Safety of NFC-1 in Adolescents With Genetic Disorders Impacting mGluR and ADHD
Phase 2/3Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 20 clinical trials
SEC Filings: 2 available